February 28, 2021
7:30 AM to 7:55 AM PST: Attendance/Exhibit
7:55 AM to 8:00 AM PST: Introduction/Welcome
8:00 AM to 8:20 AM PST: Advances in the detection of molecular driver mutations in lung adenocarcinoma, tissue vs plasma detection methods
8:20 AM to 8:30 AM PST: Discussion
8:30 AM to 8:50 AM PST: EGFR-targeted therapy in the adjuvant treatment of lung adenocarcinoma.
8:50 AM to 9:00 AM PST: Discussion
9:00 AM to 9:15 AM PST: Break
9:15 AM to 9:35 AM PST: Emerging targets for molecular therapy – an expanding array of targetable driver mutations in advanced lung adenocarcinoma.
9:35 AM to 9:45 AM PST: Discussion
9:45 AM to 10:05 AM PST: PD-L1 – recent advances in the use of checkpoint inhibitors in the management of lung adenocarcinoma.
10:00 AM to 10:15 AM PST: Discussion
10:15 AM to 10:20 AM PST: Concluding remarks